Skip to main content

CHemotaxis Inhibitory Protein of Staphylococci "CHIPS"

Objective

Inflammatory disorders are considered to be the underlying cause of at least 50 different diseases, many of which are disabling or even fatal, i.e. heart attack, rheumatoid arthritis, asthma and stroke. Current therapies are mainly treating symptoms and not the basic disease mechanisms and many of them have disturbing side effects.

In the proposed project a strategic partnership will be formed between a Swedish biotech SME, AlligatorBioscience AB, and an academic partner, the Eijkman Winkler Institute at University Medical Centre in Utrecht. Alligator specialises in development of protein based drug candidates. The unique asset of the company is the proprietary protein engineering technology FIND (Fragment INduced Diversity), which is speedy and makes it feasible to develop drugs from starting material so far not appropriate for human use. UMCU has frontline expertise in the interaction between bacteria and the human immune system, and in highly specialised cell based functional assays and animal models.

The immediate objective of the project is to pursue two different approaches to develop novel drug candidates for the treatment and basic disease modification of inflammatory disorders. The first involves de-immunisation of an already identified molecule (CHIPS) derived from Staphylococci, the second involves development of small antibody fragments that mimic the CHIPS action. The CHIPS molecule was developed by UMCU, and the group has also shown the therapeutic potential of the substance.

Further development has however so far been abandoned because of a strong immune response elicited by the molecule. The combined efforts and expertise areas of the two partners will now make a new development possible. As a long term objective the collaboration will provide both partners with technologies and a scientific contact network that will promote their future development and scientific as well as commercial competitiveness.

Field of science

  • /medical and health sciences/health sciences/public and environmental health/epidemics prevention/immunisation
  • /natural sciences/biological sciences/microbiology/virology
  • /natural sciences/chemical sciences/organic chemistry/amines
  • /natural sciences/biological sciences/biochemistry/biomolecules/proteins
  • /natural sciences/biological sciences/genetics and heredity/mutation
  • /medical and health sciences/basic medicine/immunology
  • /medical and health sciences/clinical medicine/cardiology/cardiovascular diseases

Call for proposal

FP6-2002-MOBILITY-3
See other projects for this call

Funding Scheme

TOK - Marie Curie actions-Transfer of Knowledge

Coordinator

ALLIGATOR BIOSCIENCE AB
Address
Scheelevägen 19A
Lund
Sweden

Participants (1)

UNIVERSITY MEDICAL CENTER UTRECHT
Netherlands
Address
Heidelberglaan 100
Utrecht